You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel and Selective AMPK Activator for the Treatment of Hepatocellular Carcinoma

    SBC: NOVATARG, INC.            Topic: NCI

    Project Summary/Abstract Liver cancer, primarily hepatocellular carcinoma (HCC), accounts for ~662,000 deaths each year and is the third leading cause of death from cancer worldwide. The age-adjusted incidence of HCC tripled between 1975 and 2005 in the US, and primary liver cancer mortality rates have increased faster than mortality for any other tumor type. One- and 3-year survival rates were 36 ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Improving chemotherapy outcomes with proprietary molecules targeting the human mi

    SBC: SYMBERIX, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Although non-pathogenic microbes that reside in our intestines generally provide us with numerous health and digestive benefits, a specific microfloral activity is also responsible for the severe and sometimes deadly gastrointestinal (GI) side effects of certain chemotherapeutic and pain medications. The most dangerous and well-understood example of this commen ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Instrument and Method for Forming Three-Dimensional Ultrasound Images of the Brea

    SBC: OPTOSONICS, INC.            Topic: NCI

    High Definition Ultrasound for Mammography Abstract We propose to develop High Definition Ultrasound (HD-US) based on a hemispherical synthetic aperture and backscattered sonic waves. This configuration will produce direct three-dimensional maps of ultrasound reflectivity of breast tissues, and will display higher signal-to-noise, reduced speckle and greater spatial resolution compared to ultra ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. FrostBite- A Unique Catheter for Endoscopic Cryoablation

    SBC: CELL PRESERVATION SERVICES INC            Topic: NCI

    There is a pressing need for designing new devices facilitating the development of paradigm changing, minimally invasive, approaches to treat diseased tissues in situ. Additionally, there is a growing number of studies showing that combinatorial approachesare providing a path for personalization of strategies to treat a wide array of disease states. While providing a promising path to revolutioniz ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Three Dimensional Printing of Custom Foot Orthoses to Treat Flexible Flat Feet

    SBC: SERAPH ROBOTICS, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): During Phase I of this project, Seraph Robotics will complete development and initial feasibility testing of a working prototype of a specialized 3D Printer Orthosis System for creation of multi-property custom foot orthoses. The methods to be employed include the selection of materials that are of the highest quality and have appropriate properties for the sup ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Digital Microfluidics- Minimizing blood volume for pediatric coagulation screening

    SBC: BAEBIES, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): It is reported that up to 40% of neonates undergoing cardiac surgery suffer a major thrombosis event. Pediatric patients who are at increased risk for thrombosis due to either congenital or acquired hypercoagulabilityrequire individualized anticoagulation management. Presence of a thrombophilia influences clinical decision making regarding timing and duration ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Intrasurgical Optical Coherence Tomography

    SBC: BIOPTIGEN, INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Each year, over 20 million ophthalmic surgeries are performed worldwide. Indications for ophthalmic surgery include potentially blinding diseases, such as cataracts, diabetic retinopathy, macular disease, and retinal detachment. Surgeons performing these delicate procedures are challenged by the translucent nature of tissues in the eye, making it nearly impossi ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto

    SBC: Nirvana Sciences, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Orally available transition state inhibitors for triple negative breast cancer

    SBC: NANOMETICS LLC            Topic: NCI

    Problem to be Solved: Triple-negative breast cancer (TNBC) is a deadly disease that accounts for 15-20% of all diagnosed breast cancers worldwide. Metastatic relapse of TNBC carries a poorer prognosis and lower survival rate compared to other breast cancersubtypes. Therefore, identifying novel targets and new therapeutics to treat patients diagnosed with TNBC remains a significant priority of the ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. F10: a novel therapeutic to treat refractory or relapsed AML

    SBC: SOUTHEAST TECHINVENTURES INC            Topic: NCI

    DESCRIPTION (provided by applicant): Acute myeloid leukemia (AML) affected ~14,600 new patients in 2013 in the US and caused over 10,000 deaths, primarily in older adults. The current chemotherapy regimen, a combination of cytarabine (AraC) and anthracyclines such as daunorubicin (DNR), has resulted in 5-year survival rates of only 30-40% (less than 10% in patients over 60 years old). The principa ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government